Edoxaban Antithrombotic Therapy for Atrial Fibrillation and Stable Coronary Artery Disease
In this multicenter, randomized trial, edoxaban monotherapy led to a lower risk of net clinical adverse events at 12 months than dual antithrombotic therapy...
Asundexian versus Apixaban in Patients with Atrial Fibrillation
New England Journal of Medicine, Ahead of Print.
massmed: New England Journal of Medicine: Table of Contents
PCI in Patients Undergoing Transcatheter Aortic-Valve Implantation
In a trial of percutaneous coronary intervention or conservative treatment in patients undergoing TAVI, PCI was associated with a lower risk of a composite...
Transcatheter Repair versus Mitral-Valve Surgery for Secondary Mitral Regurgitation
In a randomized trial involving patients with heart failure and secondary mitral regurgitation, transcatheter edge-to-edge repair was noninferior to mitral-valve surgery at 1-year follow-up.
The...
Continuation versus Interruption of Oral Anticoagulation during TAVI
In a randomized trial involving patients undergoing TAVI, periprocedural continuation of oral anticoagulants was not noninferior to interruption of these drugs with respect to...
